Table 6.
Recent findings in literature compared to our results.
| study | heartD mean [Gy] | whole lungD mean [Gy] | whole lungV 20 Gy [%] | ipsilateral lungD mean [Gy] | comment |
|---|---|---|---|---|---|
| Xie 2020 (56) |
3D-CRT
9.6 ± 3.7 IMRT 7.4 ± 1.3 (n.s.) |
3D-CRT
6.7 ± 1.0 IMRT 5.9 ± 0.9 (p < 0.05) |
3D-CRT
12.7 ± 2.0 IMRT 7.9 ± 2.6 (p < 0.05) |
||
| Supakalin 2018 (58) |
3D-CRT
9.5 ± 1.8 IMRT 7.7 ± 1.4 (p < 0.001) |
Left- and right-sided breast cancer | |||
| Salvestrini 2022 (49) | 1.3 - 7.2 without information on technique |
Review of mean heart doses in free breathing | |||
| Vikström 2018 (54) |
3D-CRT
6.2 ± 4.4 |
6.8 ± 1.2 | |||
| Saini 2019 (52) | 1.88 | 6.1 | |||
| Sripathi 2017 (59) |
3D-CRT
7.1 ± 3.0 IMRT 11.94 ± 1.73 |
3D-CRT
16.4 ± 4.4 IMRT 20.2 ± 1.3 |
3D-CRT
31.4 ± 10.8 IMRT 35.3 ± 7.5 |
||
| Johansen 2011 (77) | 6.5 ± 4.7 | 13.7 ± 1.9 | 3D-CRT | ||
| Edvardsson 2015 (50) | 2.5 | 5.4 | 9.1 | 3D-CRT | |
| Tommasino 2017 (55) | 3.5 | 7.6 | IMRT | ||
| Kuo 2021 (51) | 3.42 ± 1.20 | 8.81 ± 1.33 | Tangential IMRT, medium expiration | ||
| Corradini 2018 (62) | 2.54 ± 1.40 | 3.6 ± 0.8 | 3D-CRT | ||
| Haciislamoglu 2019 (65) |
3D-CRT
4.41 ± 2.2 IMRT 8.40 ± 2.54 |
3D-CRT
7.24 ± 2.59 IMRT 12.58 ± 1.75 |
3D-CRT was planned as field-in-field | ||
| Stewart 2008 (78) | 3.5 | 6.5 | 10 | 3D-CRT | |
| Taylor 2017 (57) | 5.2 | 5.7 | 9.0 | Systematic review (2010–2015) |
|
| This study |
3D-CRT + boost
4.8 ± 2.1 3D-CRT + brachy 3.3 ± 1.6 IMRT + SiB 4.4 ± 1.0 IMRT + brachy 4.5 ± 1.3 |
3D-CRT + boost
4.2 ± 1.1 3D-CRT + brachy 3.9 ± 0.8 IMRT + SiB 5.9 ± 1.3 IMRT + brachy 5.3 ± 1.6 |
3D-CRT + boost
6.3 ± 2.0 3D-CRT + brachy 6.1 ± 1.3 IMRT + SiB 8.6 ± 1.9 IMRT + brachy 7.4 ± 1.6 |
3D-CRT + boost
8.7 ± 2.2 3D-CRT + brachy 7.9 ± 1.1 IMRT + SiB 10.8 ± 1.8 IMRT + brachy 9.9 ± 2.3 |
Total dose including boost/SiB |
n.s., not significant.